Recombinant Human TFPI protein, His-Avi-tagged

• Cat.No.: TFPI-646H
• Product Overview: Recombinant Human TFPI protein(NP_001027452.1)(Asp29-Lys282) was fused to His-Avi-tagged and expressed in HEK293.

Specification

• Description: Oestrogens influence the pathophysiology and development of hormone-sensitive cancers, such as breast cancer. Tissue factor pathway inhibitor (TFPI) is a serine protease inhibitor of the extrinsic coagulation pathway and has recently been associated with breast cancer cell development.
• Source: HEK293
• Species: Human
• Tag: His-Avi
• Form: Supplied as 0.22μm filtered solution in PBS(pH 7.4).
• Molecular Mass: The protein has a predicted MW of 32.1 kDa. Due to glycosylation, the protein migrates to 40-50 kDa based on Bis-Tris PAGE result.
• Protein length: Asp29-Lys282
• Endotoxin: Less than 0.05 EU per μg by the LAL method.
• Purity: >95% as determined by Bis-Tris PAGE; >95% as determined by HPLC
  > 95% as determined by Bis-Tris PAGE
• Storage: The product should be stored at -70°C. Please do not repeated freeze-thaw cycles.

Gene Information

• Gene Name: TFPI
• Official Symbol: TFPI
• Synonyms: LACI, TFPI1, EPI, TFI
• Gene ID: 7035
• mRNA Refseq: NM_001032281.3
• Protein Refseq: NP_001027452.1
• MIM: 152310
• UniProt ID: P10646